Comparative analysis of serum antibody responses to H.Pylori and to recombinant CAGA in the cohort of working-age moscow adults

Cover Page

Cite item

Full Text

Abstract

Introduction. Helicobacter pylori (Hр) is a helix-shaped bacterium adapted evolutionary to living in the mucoid of stomach. Considered usually as one of the factors in the development of gastritis, peptic ulcer and gastric cancer, but the opposite opinions were also discussed. The aim of this study was to assess levels of serum antibodies to Hp and recombinant CagA in the cohort of working-age Moscow adults. 

Methods. Commercial ELISA kits “IFA-Helicobacter IgG”© (ZAO EKOlab, Russia) and “HelicoBest-antibodies”© (ZAO Vector-Best, Russia) were applied for the estimation of serum antibodies to Hp and CagA, correspondingly, in the observed cohort (both gender adults, N=319). 

Results. 85 % of the human cohort (N=271) had positive rates of IgG-antibodies against complex Hp antigen, with lognormal distribution of IgG titers (median 1:688; Q1 — Q3 1:370 - 1:1223) and cut-off value equal to 1:100. 54 % of the human cohort (N=172) were seropositive to recombinant CagA, with the levels of total serum antibodies (IgM, IgA and IgG) from 23 to 129 elisa units (median 87,9; Q1 — Q3 56,7 — 102,5) and cut-off value equal to 18,5 EU. The distribution of CagA antibody levels was sharply different from lognormal distribution of IgG titers to complex Hp antigen and had signs of bimodality with the main maximum shifted to the right. In the complete cohort under observation (N=319), the levels of serum antibodies to Hp and CagA were associated with a weak (R=0,217), but highly significant (p=0,00009) positive linkage; human persons, seropositive to both antigens, had no any association between the markers. 

Discussion. Possible reasons of differences in the shape of distributions of the studied markers are discussed. Taking into account the extraordinary genetic variability of natural Hp isolates, lognormal distribution of antibodies to complex Hp antigen can reflect combinatorial differences in the degree of proximity of Hp antigenic determinants between human persons under observation and the antigenic preparation. Bimodal distribution of antibody levels to individual protein CagA, possibly, reflect genetically determined differences in immunoreactivity inside the observed cohort.

About the authors

Ludmila V. Khripach

Centre for Strategic Planning, Russian Ministry of Health

Author for correspondence.
Email: lkhripach@mail.ru
ORCID iD: 0000-0003-0170-3085

Dr. Sci. Biol., head of the laboratory of biochemical and molecular genetics methods, Centre for Strategic Planning, Russian Ministry of Health.

e-mail: lkhripach@mail.ru

Russian Federation

T. D. Knjazeva

Centre for Strategic Planning, Russian Ministry of Health

Email: noemail@neicon.ru
ORCID iD: 0000-0001-5279-5018
Russian Federation

S. M. Yudin

Centre for Strategic Planning, Russian Ministry of Health

Email: noemail@neicon.ru
Russian Federation

S. V. German

Centre for Strategic Planning, Russian Ministry of Health

Email: noemail@neicon.ru
ORCID iD: 0000-0002-1628-199X
Russian Federation

I. E. Zykova

Centre for Strategic Planning, Russian Ministry of Health

Email: noemail@neicon.ru
ORCID iD: 0000-0002-6711-9124
Russian Federation

References

  1. Blaser M.J. Ecology of Helicobacter pylori in the human stomach. J. Clin. Invest. 1997; 100(4): 759–762.
  2. Fuccio L., Eusebi L.H., Bazzoli F. Gastric cancer, Helicobacter pylori infection and other risk factors. World J. Gastrointest. Oncol. 2010; 2(9): 342–347.
  3. Malfertheiner P., Megraud F., O’Morain C.A., Gisbert J.P., Kuipers E.J., Axon A.T. et al. Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report. Gut. 2017; 66: 6-30.
  4. Labenz J., Blum A.L., Bayerdörffer E., Meining A., Stolte M., Börsch G. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology. 1997; 112(5):1442-1447.
  5. Chernin V.V., Bondarenko V.M., Chervinets V.M., Bazlov S.N. Helicobacter pylori as an integral part of the microbiocenosis of the mucosal microflora of the esophagogastroduodenal zone in norm and pathology. Exp. wedge. gastroenterol. 2011; No. 8: 66-72.
  6. Zimmerman Ya.S. Is the discovery of Helicobacter pylori really a revolution in gastroenterology? Klin. med. 2013; No. 8 : 13-21.
  7. Eusebi L.H., Zagari R.M., Bazzoli F. Epidemiology of Helicobacter pylori infection. Helicobacter. 2014; Suppl 1:1-5. https://doi.org/10.1111/hel.12165
  8. Li S., Lu A.-P., Zhang L., Li Y.-D. Anti-Helicobacter pylori immunoglobulin G (IgG) and IgA antibody responses and the value of clinical presentations in diagnosis of Helicobacter pylori infection in patients with precancerous lesions. World J. Gastroenterol. 2003; 9(4):755-758.
  9. Homeriki S.G., Kasyanenko V.I. Laboratory diagnostics of Helicobacter pylori infection - St. Petersburg: LLC "AMA", 2011. - 110 P.
  10. Klimovich A.V. Creation of immunochemical reagents for the detection of Helicobacter pylori CagA antigen and antibodies against it. Abstract of the candidate. dissertations. Saint Petersburg, 2010. - 20 P.
  11. Vartanova N.O., Arzumanyan N.O., Poddubikov A.V., Vaneeva N.P., Serdyuk O.A. Improving the immunodiagnostics of helicobacteriosis. Epidemiology and vaccination prevention. 2007; № 4: 34-37.
  12. Hoang T.T., Wheeldon T.U., Bengtsson G., Phung D.C., Sorberg M., Granstrom M. Enzyme-linked immunosorbent assay for Helicobacter pylori needs adjustment for the population investigated. J. Clin. Microbiol. 2004; 42(2): 627–630.
  13. Yan J., Mao Y.-F., Shao Z.-X. Frequencies of the expression of main protein antigens from Helicobacter pylori isolates and production of specific serum antibodies in infected patients. World J. Gastroenterol. 2005;11(3):421-425
  14. Akada J., Okuda M., Hiramoto N., Kitagawa T., Zhang X., Kamei S. et al. Proteomic characterization of Helicobacter pylori CagA antigen recognized by child serum antibodies and its epitope mapping by peptide array. PLoS ONE. 2014; 9(8): e104611. https://doi.org/10.1371/journal.pone.0104611
  15. Censini S., Lange C., Xiang Z., Crabtree J.E., Ghiara P., Borodovsky M. et al. Cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc. Natl. Acad. Sci. USA. 1996; 93(25):14648-14653.
  16. Naito M., Yamazaki T., Tsutsumi R., Higashi H., Onoe K., Yamazaki S. et al. Influence of EPIYA-repeat polymorphism on the phosphorylation-dependent biological activity of Helicobacter pylori CagA. Gastroenterology. 2006; 130(4): 1181-1190.
  17. Jones K.R., Joo Y.M., Jang S., Yoo Y.J., Lee H.S., Chung I.S. et al. Polymorphism in the CagA EPIYA motif impacts development of gastric cancer. J. Clin. Microbiol. 2009; 47(4): 959-968.
  18. Keates S., Sougioultzis S., Keates A.C., Zhao D., Peek R.M., Shaw L.M. et al. Cag+ Helicobacter pylori induce transactivation of the epidermal growth factor receptor in AGS gastric epithelial cells. J. Biol. Chem. 2001; 276(51): 48127-48134.
  19. Cardoso L., Lopes A.P., Sherry K., Schallig H., Solano-Gallego L. Low seroprevalence of Leishmania infantum infection in cats from northern Portugal based on DAT and ELISA. Vet. Parasitol. 2010; 174(1-2): 37-42.
  20. Reshetnikov O.V., Kurilovich S.A., Krotov S.A., Krotova V.A. Helicobacter infection in Siberian populations. Byull. WITH RAMS. 2010; 30(2): 88-93.
  21. Herman S.V., Zykova I.E., Modestova A.V., Ermakov N.V. Prevalence of H. pylori infection among the population of Moscow. Ross. journal. gastroenterol., hepatol., coloproctol. 2010; No. 2: 25-30.
  22. Rakhmanin Yu.A., Zykova I.E., Fedichkina T.P., Solenova L.G., Herman S.V., Modestova A.V., etc. The study of the territorial distribution of Helicobacter pylori infection in the able-bodied population of Moscow during the medical examination of production contingents. Hygiene and sanitation. 2013; №5: 79-82.
  23. Makarenko E.V. Pimanov S.I., Voropaeva A.V., Bondarenko V.M. The prevalence of Helicobacter pylori infection in the Vitebsk region. Bulletin of the Vitebsk State Medical University. 2005; 4(4): 12-19.
  24. Vorobjova T., Nilsson I., Kull K., Maaroos H.I., Covacci A., Wadstrom T. et al. CagA protein seropositivity in a random sample of adult population and gastric cancer patients in Estonia. Eur. J. Gastroenterol. Hepatol. 1998; 10: 41–46.
  25. Fusconi M., Vaira D., Menegatti M., Farinelli S., Figura N., Holton J. et al. Anti-CagA reactivity in Helicobacter pylori-negative subjects. Digestive Diseases and Sciences. 1999; 44(8): 1691-1695.
  26. Han Y.H., Liu W.Z., Shi Y.Z., Lu L.Q., Xiao S., Zhang Q.H. et al. Comparative genomics profiling of clinical isolates of Helicobacter pylori in Chinese populations using DNA microarray. J Microbiol. 2007; 45(1): 21-28.
  27. Momynaliev K.T. Genomic-proteomic characteristics of Helicobacter pylori variability. Abstract of the doct. dissertations. Moscow, 2009– - 45 P.
  28. Bereznyak E.A., Sorokin V.M., Karpova I.O., Stupina N.A., Terentyev A.N. Features of 23 genotypes of Helicobacter pylori strains circulating in the Rostov region. Epidemiology and Vaccination Prevention. 2013; № 4: 30-33.
  29. Siman F.H., Engstrand L., Berglund G., Floren C.H., Forsgren A. Evaluation of western blot CagA seropositivity in Helicobacter pylori-seroposit -seronegative subjects. Clin. Diagn. Lab. Immunol. 2005; 12(2): 304-309.
  30. Matsuo Y. Kido Y., Akada J., Shiota S., Binh T.T., Trang T. et al. Novel CagA ELISA exhibits enhanced sensitivity of Helicobacter pylori CagA antibody. World J. Gastroenterol. 2017; 23(1): 48-59.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2024 Khripach L.V., Knjazeva T.D., Yudin S.M., German S.V., Zykova I.E.


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 37884 от 02.10.2009.